<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35996201</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>BDNF-dependent modulation of axonal transport is selectively impaired in ALS.</ArticleTitle><Pagination><StartPage>121</StartPage><MedlinePgn>121</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-022-01418-4</ELocationID><Abstract><AbstractText>Axonal transport ensures long-range delivery of essential cargoes between proximal and distal compartments, and is needed for neuronal development, function, and survival. Deficits in axonal transport have been detected at pre-symptomatic stages in the SOD1<sup>G93A</sup> and TDP-43<sup>M337V</sup> mouse models of amyotrophic lateral sclerosis (ALS), suggesting that impairments in this critical process are fundamental for disease pathogenesis. Strikingly, in ALS, fast motor neurons (FMNs) degenerate first whereas slow motor neurons (SMNs) are more resistant, and this is a currently unexplained phenomenon. The main aim of this investigation was to determine the effects of brain-derived neurotrophic factor (BDNF) on in vivo axonal transport in different &#x3b1;-motor neuron (MN) subtypes in wild-type (WT) and SOD1<sup>G93A</sup> mice. We report that despite displaying similar basal transport speeds, stimulation of wild-type MNs with BDNF enhances in vivo trafficking of signalling endosomes specifically in FMNs. This BDNF-mediated enhancement of transport was also observed in primary ventral horn neuronal cultures. However, FMNs display selective impairment of axonal transport in vivo in symptomatic SOD1<sup>G93A</sup> mice, and are refractory to BDNF stimulation, a phenotype that was also observed in primary embryonic SOD1<sup>G93A</sup> neurons. Furthermore, symptomatic SOD1<sup>G93A</sup> mice display upregulation of the classical non-pro-survival truncated TrkB and p75<sup>NTR</sup> receptors in muscles, sciatic nerves, and Schwann cells. Altogether, these data indicate that cell- and non-cell autonomous BDNF signalling is impaired in SOD1<sup>G93A</sup> MNs, thus identifying a new key deficit in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tosolini</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-7651-7442</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. a.tosolini@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK. a.tosolini@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sleigh</LastName><ForeName>James N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0002-3782-9045</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute, University College London, London, WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Surana</LastName><ForeName>Sunaina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7017-3105</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute, University College London, London, WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhymes</LastName><ForeName>Elena R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0002-7103-5513</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cahalan</LastName><ForeName>Stephen D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0003-2287-1416</Identifier><AffiliationInfo><Affiliation>Comparative Neuromuscular Disease Laboratory, Department of Clinical Sciences and Services, Royal Veterinary College, University of London, London, NW1 0TU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiavo</LastName><ForeName>Giampietro</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4319-8745</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. giampietro.schiavo@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK. giampietro.schiavo@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute, University College London, London, WC1E 6BT, UK. giampietro.schiavo@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006990/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000629684">Bdnf protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="Y">Axonal Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="Y">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Axonal transport</Keyword><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">Motor neuron</Keyword><Keyword MajorTopicYN="N">TrkB</Keyword><Keyword MajorTopicYN="N">p75NTR</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>22</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35996201</ArticleId><ArticleId IdType="pmc">PMC9396851</ArticleId><ArticleId IdType="doi">10.1186/s40478-022-01418-4</ArticleId><ArticleId IdType="pii">10.1186/s40478-022-01418-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research? Neurobiol Dis. 2017;105:283&#x2013;299. doi: 10.1016/j.nbd.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.02.004</ArticleId><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas JNS, Sleigh JN, Schiavo G. Coupling axonal mRNA transport and local translation to organelle maintenance and function. Curr Opin Cell Biol. 2022;74:97&#x2013;103. doi: 10.1016/j.ceb.2022.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC10477965</ArticleId><ArticleId IdType="pubmed">35220080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Rossor AM, Fellows AD, et al. Axonal transport and neurological disease. Nat Rev Neurol. 2019;15:691&#x2013;703. doi: 10.1038/s41582-019-0257-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0257-2</ArticleId><ArticleId IdType="pubmed">31558780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, Sahai E, Kelly G, et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci USA. 2010;107:20523&#x2013;20528. doi: 10.1073/pnas.1006869107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006869107</ArticleId><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs KL, Kalmar B, Rhymes ER, et al. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis. 2018;9:596. doi: 10.1038/s41419-018-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0624-8</ArticleId><ArticleId IdType="pmc">PMC5964181</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellows AD, Rhymes ER, Gibbs KL, et al. IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons. EMBO Rep. 2020;21:e49129. doi: 10.15252/embr.201949129.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949129</ArticleId><ArticleId IdType="pmc">PMC7054680</ArticleId><ArticleId IdType="pubmed">32030864</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhymes ER, Tosolini AP, Fellows AD, et al. Bimodal regulation of axonal transport by the GDNF-RET signalling axis in healthy and diseased motor neurons. Cell Death Dis. 2022;13:584. doi: 10.1038/s41419-022-05031-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-05031-0</ArticleId><ArticleId IdType="pmc">PMC9263112</ArticleId><ArticleId IdType="pubmed">35798698</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Tosolini AP, Gordon D, et al. Mice carrying ALS mutant TDP-43, but not mutant FUS, display in vivo defects in axonal transport of signaling endosomes. Cell Rep. 2020;30:3655&#x2013;3662.e2. doi: 10.1016/j.celrep.2020.02.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.078</ArticleId><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, et al. Motor neuron susceptibility in ALS/FTD. Front Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifani N. Motor neurons and the generation of spinal motor neuron diversity. Front Cell Neurosci. 2014;8:293. doi: 10.3389/fncel.2014.00293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00293</ArticleId><ArticleId IdType="pmc">PMC4191298</ArticleId><ArticleId IdType="pubmed">25346659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanning KC, Kaplan A, Henderson CE. Motor neuron diversity in development and disease. Annu Rev Neurosci. 2010;33:409&#x2013;440. doi: 10.1146/annurev.neuro.051508.135722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.051508.135722</ArticleId><ArticleId IdType="pubmed">20367447</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JA, Klemm S, Shadrach JL, et al. Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons. Nat Neurosci. 2021;24:572&#x2013;583. doi: 10.1038/s41593-020-00795-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00795-0</ArticleId><ArticleId IdType="pmc">PMC8016743</ArticleId><ArticleId IdType="pubmed">33589834</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, et al. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9:408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E, Martineau &#xc9;, Robitaille R. Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: when motor units matter. J Neurosci. 2017;37:8901&#x2013;8918. doi: 10.1523/JNEUROSCI.3090-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3090-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein SY, Yagudayeva I, Shneider NA. Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Rep. 2019;26:364&#x2013;373.e4. doi: 10.1016/j.celrep.2018.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.045</ArticleId><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, et al. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med. 2022;28:104&#x2013;116. doi: 10.1038/s41591-021-01615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Delezie J, Weihrauch M, Maier G, et al. BDNF is a mediator of glycolytic fiber-type specification in mouse skeletal muscle. Proc Natl Acad Sci USA. 2019;116:16111&#x2013;16120. doi: 10.1073/pnas.1900544116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1900544116</ArticleId><ArticleId IdType="pmc">PMC6690026</ArticleId><ArticleId IdType="pubmed">31320589</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforges S, Branchu J, Biondi O, et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol. 2009;587:3561&#x2013;3572. doi: 10.1113/jphysiol.2009.169748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.169748</ArticleId><ArticleId IdType="pmc">PMC2742281</ArticleId><ArticleId IdType="pubmed">19491245</ArticleId></ArticleIdList></Reference><Reference><Citation>Peggion C, Massimino ML, Biancotto G, et al. Absolute quantification of myosin heavy chain isoforms by selected reaction monitoring can underscore skeletal muscle changes in a mouse model of amyotrophic lateral sclerosis. Anal Bioanal Chem. 2017;409:2143&#x2013;2153. doi: 10.1007/s00216-016-0160-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-016-0160-2</ArticleId><ArticleId IdType="pubmed">28078418</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhindi A, Boehm I, Chaytow H. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS) J Anat. 2021 doi: 10.1111/joa.13463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.13463</ArticleId><ArticleId IdType="pmc">PMC9558162</ArticleId><ArticleId IdType="pubmed">34101196</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins TM, Alix JJP, Fingret J, et al. Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease. J Neurol. 2020;267:244&#x2013;256. doi: 10.1007/s00415-019-09580-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09580-x</ArticleId><ArticleId IdType="pmc">PMC6954906</ArticleId><ArticleId IdType="pubmed">31624953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol. 2008;586:3337&#x2013;3351. doi: 10.1113/jphysiol.2007.149286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pmc">PMC2538809</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, Schlagowski A, Ngo ST, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Lepore E, Martini M, et al. Metabolic changes associated with muscle expression of SOD1G93A. Front Physiol. 2018;9:831. doi: 10.3389/fphys.2018.00831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller S, Buttigieg D, Alory A, et al. Novel combinatorial screening identifies neurotrophic factors for selective classes of motor neurons. Proc Natl Acad Sci USA. 2017;114:E2486&#x2013;E2493. doi: 10.1073/pnas.1615372114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1615372114</ArticleId><ArticleId IdType="pmc">PMC5373341</ArticleId><ArticleId IdType="pubmed">28270618</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia JC, Kelahmetoglu Y, Jannig PR, et al. Muscle-secreted neurturin couples myofiber oxidative metabolism and slow motor neuron identity. Cell Metab. 2021;33:2215&#x2013;2230.e8. doi: 10.1016/j.cmet.2021.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.003</ArticleId><ArticleId IdType="pubmed">34592133</ArticleId></ArticleIdList></Reference><Reference><Citation>Shneider NA, Brown MN, Smith CA, et al. Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev. 2009;4:42. doi: 10.1186/1749-8104-4-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8104-4-42</ArticleId><ArticleId IdType="pmc">PMC2800842</ArticleId><ArticleId IdType="pubmed">19954518</ArticleId></ArticleIdList></Reference><Reference><Citation>Armanini MP, McMahon SB, Sutherland J, et al. Truncated and catalytic isoforms of trkB are co-expressed in neurons of rat and mouse CNS. Eur J Neurosci. 1995;7:1403&#x2013;1409. doi: 10.1111/j.1460-9568.1995.tb01132.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1995.tb01132.x</ArticleId><ArticleId IdType="pubmed">7582115</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4:299&#x2013;309. doi: 10.1038/nrn1078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1078</ArticleId><ArticleId IdType="pubmed">12671646</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessarollo L, Yanpallewar S. Trkb truncated isoform receptors as transducers and determinants of BDNF functions. Front Neurosci. 2022;16:847572. doi: 10.3389/fnins.2022.847572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.847572</ArticleId><ArticleId IdType="pmc">PMC8934854</ArticleId><ArticleId IdType="pubmed">35321093</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeldal S, Matusica D, Nykjaer A, Coulson EJ. Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling?: neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR) BioEssays. 2011;33:614&#x2013;625. doi: 10.1002/bies.201100036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201100036</ArticleId><ArticleId IdType="pubmed">21717487</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez V, Bermedo-Garcia F, Zelada D, et al. The p75NTR neurotrophin receptor is required to organize the mature neuromuscular synapse by regulating synaptic vesicle availability. Acta Neuropathol Commun. 2019;7:147. doi: 10.1186/s40478-019-0802-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0802-7</ArticleId><ArticleId IdType="pmc">PMC6739937</ArticleId><ArticleId IdType="pubmed">31514753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurtado E, Cilleros V, Nadal L, et al. Muscle contraction regulates BDNF/TrkB signaling to modulate synaptic function through presynaptic cPKC&#x3b1; and cPKC&#x3b2;I. Front Mol Neurosci. 2017;10:147. doi: 10.3389/fnmol.2017.00147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00147</ArticleId><ArticleId IdType="pmc">PMC5436293</ArticleId><ArticleId IdType="pubmed">28572757</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T, Sobue G, Hamano T, et al. Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem Res. 2000;25:239&#x2013;245. doi: 10.1023/a:1007575504321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1007575504321</ArticleId><ArticleId IdType="pubmed">10786708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry KS, Murray SS, McLean CA, et al. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:127&#x2013;134. doi: 10.1080/146608201753275463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608201753275463</ArticleId><ArticleId IdType="pubmed">11771768</ArticleId></ArticleIdList></Reference><Reference><Citation>Moya-Alvarado G, Guerra MV, Wu C, et al. BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons. BioRxiv. 2020 doi: 10.1101/2020.08.22.262923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.22.262923</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos AR, Comprido D, Duarte CB. Regulation of local translation at the synapse by BDNF. Prog Neurobiol. 2010;92:505&#x2013;516. doi: 10.1016/j.pneurobio.2010.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2010.08.004</ArticleId><ArticleId IdType="pubmed">20713125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazo OM, Schiavo G. Rab10 regulates the sorting of internalised TrkB to retrograde axonal transport. BioRxiv. 2021 doi: 10.1101/2021.04.07.438771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.07.438771</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt K, Salinas S, Verastegui C, et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron. 2006;52:293&#x2013;305. doi: 10.1016/j.neuron.2006.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.08.018</ArticleId><ArticleId IdType="pubmed">17046692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Martin S, Nguyen TH, et al. Flux of signalling endosomes undergoing axonal retrograde transport is encoded by presynaptic activity and TrkB. Nat Commun. 2016;7:12976. doi: 10.1038/ncomms12976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12976</ArticleId><ArticleId IdType="pmc">PMC5427517</ArticleId><ArticleId IdType="pubmed">27687129</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci. 2005;236:1&#x2013;7. doi: 10.1016/j.jns.2005.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Schiavo G. Older but not slower: aging does not alter axonal transport dynamics of signalling endosomes in vivo. Matters. 2016 doi: 10.19185/matters.201605000018.</Citation><ArticleIdList><ArticleId IdType="doi">10.19185/matters.201605000018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Tosolini AP, Schiavo G. In vivo imaging of anterograde and retrograde axonal transport in rodent peripheral nerves. Methods Mol Biol. 2020;2143:271&#x2013;292. doi: 10.1007/978-1-0716-0585-1_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-0585-1_20</ArticleId><ArticleId IdType="pmc">PMC7116510</ArticleId><ArticleId IdType="pubmed">32524487</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosolini AP, Villarroel-Campos D, Schiavo G, Sleigh JN. Expanding the toolkit for in vivo imaging of axonal transport. J Vis Exp. 2021 doi: 10.3791/63471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/63471</ArticleId><ArticleId IdType="pubmed">35001910</ArticleId></ArticleIdList></Reference><Reference><Citation>Restani L, Giribaldi F, Manich M, et al. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog. 2012;8:e1003087. doi: 10.1371/journal.ppat.1003087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003087</ArticleId><ArticleId IdType="pmc">PMC3531519</ArticleId><ArticleId IdType="pubmed">23300443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan R, Tosolini AP, Morris R. Targeting the motor end plates in the mouse hindlimb gives access to a greater number of spinal cord motor neurons: an approach to maximize retrograde transport. Neuroscience. 2014;274:318&#x2013;330. doi: 10.1016/j.neuroscience.2014.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.05.045</ArticleId><ArticleId IdType="pubmed">24892760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan R, Tosolini AP, Morris R. Intramuscular injections along the motor end plates: a minimally invasive approach to shuttle tracers directly into motor neurons. J Vis Exp. 2015 doi: 10.3791/52846.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52846</ArticleId><ArticleId IdType="pmc">PMC4545031</ArticleId><ArticleId IdType="pubmed">26273739</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinevez J-Y, Perry N, Schindelin J, et al. TrackMate: an open and extensible platform for single-particle tracking. Methods. 2017;115:80&#x2013;90. doi: 10.1016/j.ymeth.2016.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2016.09.016</ArticleId><ArticleId IdType="pubmed">27713081</ArticleId></ArticleIdList></Reference><Reference><Citation>Welinder C, Ekblad L. Coomassie staining as loading control in Western blot analysis. J Proteome Res. 2011;10:1416&#x2013;1419. doi: 10.1021/pr1011476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr1011476</ArticleId><ArticleId IdType="pubmed">21186791</ArticleId></ArticleIdList></Reference><Reference><Citation>Degasperi A, Birtwistle MR, Volinsky N, et al. Evaluating strategies to normalise biological replicates of Western blot data. PLoS ONE. 2014;9:e87293. doi: 10.1371/journal.pone.0087293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087293</ArticleId><ArticleId IdType="pmc">PMC3903630</ArticleId><ArticleId IdType="pubmed">24475266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyckelsma VL, McKenna MJ, Levinger I, et al. Cell specific differences in the protein abundances of GAPDH and Na(+), K(+)-ATPase in skeletal muscle from aged individuals. Exp Gerontol. 2016;75:8&#x2013;15. doi: 10.1016/j.exger.2015.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2015.12.010</ArticleId><ArticleId IdType="pubmed">26747222</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigels&#xf8; A, Dybboe R, Hansen CN, et al. GAPDH and &#x3b2;-actin protein decreases with aging, making Stain-Free technology a superior loading control in Western blotting of human skeletal muscle. J Appl Physiol. 2015;118:386&#x2013;394. doi: 10.1152/japplphysiol.00840.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00840.2014</ArticleId><ArticleId IdType="pubmed">25429098</ArticleId></ArticleIdList></Reference><Reference><Citation>Surana S, Tosolini AP, Meyer IFG, et al. The travel diaries of tetanus and botulinum neurotoxins. Toxicon. 2018;147:58&#x2013;67. doi: 10.1016/j.toxicon.2017.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2017.10.008</ArticleId><ArticleId IdType="pubmed">29031941</ArticleId></ArticleIdList></Reference><Reference><Citation>Surana S, Villarroel-Campos D, Lazo OM, et al. The evolution of the axonal transport toolkit. Traffic. 2020;21:13&#x2013;33. doi: 10.1111/tra.12710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12710</ArticleId><ArticleId IdType="pubmed">31670447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercsenyi K, Schmieg N, Bryson JB, et al. Tetanus toxin entry. nidogens are therapeutic targets for the prevention of tetanus. Science. 2014;346:1118&#x2013;1123. doi: 10.1126/science.1258138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258138</ArticleId><ArticleId IdType="pubmed">25430769</ArticleId></ArticleIdList></Reference><Reference><Citation>Che DL, Chowdary PD, Cui B. A close look at axonal transport: cargos slow down when crossing stationary organelles. Neurosci Lett. 2016;610:110&#x2013;116. doi: 10.1016/j.neulet.2015.10.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.10.066</ArticleId><ArticleId IdType="pmc">PMC4695265</ArticleId><ArticleId IdType="pubmed">26528790</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Sun W, Wang G, et al. Rotational dynamics of cargos at pauses during axonal transport. Nat Commun. 2012;3:1030. doi: 10.1038/ncomms2037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2037</ArticleId><ArticleId IdType="pubmed">22929787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross JL, Ali MY, Warshaw DM. Cargo transport: molecular motors navigate a complex cytoskeleton. Curr Opin Cell Biol. 2008;20:41&#x2013;47. doi: 10.1016/j.ceb.2007.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2007.11.006</ArticleId><ArticleId IdType="pmc">PMC2688467</ArticleId><ArticleId IdType="pubmed">18226515</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Cai Q, Xie Y, Sheng Z-H. Snapin recruits dynein to BDNF-TrkB signaling endosomes for retrograde axonal transport and is essential for dendrite growth of cortical neurons. Cell Rep. 2012;2:42&#x2013;51. doi: 10.1016/j.celrep.2012.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.06.010</ArticleId><ArticleId IdType="pmc">PMC3408618</ArticleId><ArticleId IdType="pubmed">22840395</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni J-M, Lin JQ, Holtermann AV, et al. Late endosomes act as mRNA translation platforms and sustain mitochondria in axons. Cell. 2019;176:56&#x2013;72.e15. doi: 10.1016/j.cell.2018.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.11.030</ArticleId><ArticleId IdType="pmc">PMC6333918</ArticleId><ArticleId IdType="pubmed">30612743</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B, Nirmalananthan N, Bilsland LG, et al. Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum Mol Genet. 2011;20:1776&#x2013;1786. doi: 10.1093/hmg/ddr061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr061</ArticleId><ArticleId IdType="pmc">PMC3071673</ArticleId><ArticleId IdType="pubmed">21317158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Str&#xf6;m A-L, Fukada K, et al. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem. 2007;282:16691&#x2013;16699. doi: 10.1074/jbc.M609743200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609743200</ArticleId><ArticleId IdType="pubmed">17403682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J, Kuang L, Barnett KR, et al. ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics. Acta Neuropathol. 2016;132:563&#x2013;576. doi: 10.1007/s00401-016-1601-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1601-x</ArticleId><ArticleId IdType="pmc">PMC5023729</ArticleId><ArticleId IdType="pubmed">27481264</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau &#xc9;, Di Polo A, Vande Velde C, Robitaille R. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. Elife. 2018 doi: 10.7554/eLife.41973.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41973</ArticleId><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith KS, Rush RA, Rogers M-L. Characterization and changes in neurotrophin receptor p75-expressing motor neurons in SOD1(G93A) G1H mice [corrected] J Comp Neurol. 2015;523:1664&#x2013;1682. doi: 10.1002/cne.23763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23763</ArticleId><ArticleId IdType="pubmed">25711805</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanpallewar SU, Barrick CA, Buckley H, et al. Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e39946. doi: 10.1371/journal.pone.0039946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039946</ArticleId><ArticleId IdType="pmc">PMC3384607</ArticleId><ArticleId IdType="pubmed">22761934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanpallewar S, Fulgenzi G, Tomassoni-Ardori F, et al. Delayed onset of inherited ALS by deletion of the BDNF receptor TrkB.T1 is non-cell autonomous. Exp Neurol. 2021;337:113576. doi: 10.1016/j.expneurol.2020.113576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113576</ArticleId><ArticleId IdType="pmc">PMC9229840</ArticleId><ArticleId IdType="pubmed">33359475</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wit J, Eggers R, Evers R, et al. Long-term adeno-associated viral vector-mediated expression of truncated TrkB in the adult rat facial nucleus results in motor neuron degeneration. J Neurosci. 2006;26:1516&#x2013;1530. doi: 10.1523/JNEUROSCI.4543-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4543-05.2006</ArticleId><ArticleId IdType="pmc">PMC6675476</ArticleId><ArticleId IdType="pubmed">16452675</ArticleId></ArticleIdList></Reference><Reference><Citation>Matusica D, Alfonsi F, Turner BJ, et al. Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment. J Cell Sci. 2016;129:517&#x2013;530. doi: 10.1242/jcs.173864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.173864</ArticleId><ArticleId IdType="pubmed">26503157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundby A, Lage K, Weinert BT, et al. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep. 2012;2:419&#x2013;431. doi: 10.1016/j.celrep.2012.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.07.006</ArticleId><ArticleId IdType="pmc">PMC4103158</ArticleId><ArticleId IdType="pubmed">22902405</ArticleId></ArticleIdList></Reference><Reference><Citation>Haniu M, Talvenheimo J, Le J, et al. Extracellular domain of neurotrophin receptor trkB: disulfide structure, N-glycosylation sites, and ligand binding. Arch Biochem Biophys. 1995;322:256&#x2013;264. doi: 10.1006/abbi.1995.1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1995.1460</ArticleId><ArticleId IdType="pubmed">7574684</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin AN, Shooter EM. Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel N-glycosylation sites. J Biol Chem. 1995;270:4594&#x2013;4602. doi: 10.1074/jbc.270.9.4594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.9.4594</ArticleId><ArticleId IdType="pubmed">7876230</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasia A, Barker PA, Chao MV, Hempstead BL. Detection of p75NTR Trimers: Implications for Receptor Stoichiometry and Activation. J Neurosci. 2015;35:11911&#x2013;11920. doi: 10.1523/JNEUROSCI.0591-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0591-15.2015</ArticleId><ArticleId IdType="pmc">PMC4549402</ArticleId><ArticleId IdType="pubmed">26311773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>